Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer

PURPOSE: Anti-human epidermal growth factor receptor 2 (HER2) therapies are associated with interstitial lung disease (ILD), also referred to as pneumonitis. In this literature review, we describe the incidence of ILD among patients with HER2-positive metastatic breast cancer (MBC) receiving anti-HE...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Breast Cancer Res Treat
Main Authors: Hackshaw, Michelle D., Danysh, Heather E., Singh, Jasmeet, Ritchey, Mary E., Ladner, Amy, Taitt, Corina, Camidge, D. Ross, Iwata, Hiroji, Powell, Charles A.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer US 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7376509/
https://ncbi.nlm.nih.gov/pubmed/32591987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-020-05754-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados